Group Dinner Meeting with Management in New York on December 2 hosted by Oppenheimer.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AQST:
- Buy Rating for Aquestive Therapeutics Driven by Anaphylm’s FDA Approval Prospects and Market Potential
- Aquestive Therapeutics price target raised to $8 from $5 at Piper Sandler
- Aquestive Therapeutics Reports Q3 2025 Financial Results
- Aquestive Therapeutics’ Earnings Call: Optimism Amid Challenges
- Aquestive Therapeutics Advances Anaphylm Towards FDA Approval